0001209191-20-064066.txt : 20201217
0001209191-20-064066.hdr.sgml : 20201217
20201217163339
ACCESSION NUMBER: 0001209191-20-064066
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201215
FILED AS OF DATE: 20201217
DATE AS OF CHANGE: 20201217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lawton Alison Frances
CENTRAL INDEX KEY: 0001542650
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37722
FILM NUMBER: 201396499
MAIL ADDRESS:
STREET 1: 39 ROBINSON ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02420
FORMER NAME:
FORMER CONFORMED NAME: LAWTON ALISON FRANCIS
DATE OF NAME CHANGE: 20120216
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aeglea BioTherapeutics, Inc.
CENTRAL INDEX KEY: 0001636282
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 464312787
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
BUSINESS PHONE: (512) 942-2935
MAIL ADDRESS:
STREET 1: 805 LAS CIMAS PARKWAY
STREET 2: SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78746
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-15
0
0001636282
Aeglea BioTherapeutics, Inc.
AGLE
0001542650
Lawton Alison Frances
C/O AEGLEA BIOTHERAPEUTICS, INC.
805 LAS CIMAS PARKWAY, SUITE 100
AUSTIN
TX
78746
1
0
0
0
Director Stock Option (right to buy)
9.09
2020-12-15
4
A
0
47200
0.00
A
2030-12-14
Common Stock
47200
47200
D
The stock option vests and becomes exercisable in 36 equal monthly installments beginning on January 15, 2021 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
/s/ Charles N. York II, by power of attorney
2020-12-17